The Epilepsy Study Consortium is a group of scientific investigators from academic medical research centers who are dedicated to accelerating the development of new therapies in epilepsy to improve patient care. The organization’s goals include building a partnership between academics, industry and regulatory agencies and optimizing clinical trial methodology in order to responsibly speed new treatments to patients.

• President: Jacqueline French, M.D.
• Vice-President: Gregory Krauss, M.D.
• Treasurer: James Lintott, Esq.
• Executive Director: Mary Ann Brodie
• Co-Executive Director: Bree Vogelsong